Knowledge Center
Article / Aug 01, 2014
Pharmaceutical Manufacturing and Supply-Chain Trends to 2020
Source:
Pharmaceutical Technology Europe, August 2014
A breach in the pharmaceutical supply chain is only the tip of the iceberg.
Innovators (Big Pharma and biotech companies) are today a minority player supplying only about 20% of the world’s medicines. At present, the vast majority of medicines are generic—the fruits of the best science of the 20th century can now be enjoyed for a few cents a pill.
Related links
Also in the Knowledge Center
/ Jan 01, 1989
Rhodium-containing hydrogenation catalysts for the conversion of methacycline to doxycycline
Read more
Scientific Article
/ Jan 01, 1989
Rhodium hydrogenation catalysts particularly for stereoselective hydrogenation of methacycline to doxycycline
Read more
Scientific Article
/ Jan 01, 1989
Homogeneous catalytic system for hydrogenation of methylenetetracyclines and a process for the preparation of same
Read more
Scientific Article